Dixon Tech faces Vivo delay as EPS estimate falls 7%

Technologies (India) Limited (DIXON) fell 2.4% to ₹13,030 on September 22 after Nuvama cut its FY27 EPS estimate by 7%. The brokerage expects the Dixon-Vivo joint venture to operationalise in Q3FY27, later than its earlier October timeline. It retained a Hold rating and raised its September 2027 target to ₹14,800 from ₹13,700. My view is that the near-term earnings cut is mainly timing-related, while the broader growth story remains linked to Vivo, components and exports. Nuvama expects FY27 smartphone volumes at 9.4–9.5 million units in Q2, down 10–12% YoY, but this would still indicate market-share gains for Dixon. The bigger concern is the smartphone demand environment. Nuvama expects the domestic market to contract another 15–20% YoY in Q2 as higher memory-chip prices push up handset prices, particularly affecting the mid- and low-end segments. Export realisations are also becoming harder to achieve. At the same time, Dixon is targeting 7–7.5 crore annual smartphone volumes and ₹1.05–1.10 lakh crore of mobile-phone revenue. Telecom and IT hardware are additional growth areas, with FY27 revenue anticipated at ₹6,500–7,000 crore and above ₹6,000 crore, respectively. My stance: The Vivo JV delay and weaker smartphone demand create near-term earnings pressure, while component scale-up and export recovery remain key triggers. Investors should track JV commencement, smartphone volumes, export recovery and margin improvement. Disclosure: I do not hold any position in Dixon Technologies (India) Limited (DIXON). This post is for informational purposes only and is not investment advice.